This study demonstrated that celastrol affects B16-F10 melanoma cells by inhibiting the PI3K/AKT/mTOR signaling pathway and the expression of HIF-α mRNA, indicating that celastrol inhibits B16-F10 melanoma cell migration and survival. The gene discussed is AKT1; the disease is melanoma.